Document ID: SEC-2015-1086-0001
Agency: sec
Document Type: Notice
Title: Trading Suspension Orders: Accres Holding, Inc., et al.
Posted Date: 2015-06-30T04:00Z

[Federal Register Volume 80, Number 125 (Tuesday, June 30, 2015)]
[Notices]
[Pages 37329-37330]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-16147]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]

 In the Matter of Accres Holding, Inc., FirstBank Financial 
Services, Inc., MicroSmart Devices, Inc., Polymedix, Inc., RegenoCELL 
Therapeutics, Inc., and The Sagemark Companies Ltd.; Order of 
Suspension of Trading

June 26, 2015.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Accres Holding, Inc. (CIK No. 1158201) (``ACCE'' \1\), a void Delaware 
corporation with its principal place of business in Shelton, 
Connecticut, with stock quoted on OTC Link (previously, ``Pink 
Sheets'') operated by OTC Markets Group Inc. (``OTC Link'') because it 
has not filed any periodic reports since the period ended September 30, 
2010. On June 27, 2013, the Division of Corporation Finance 
(``Corporation Finance'') sent a delinquency letter to ACCE requesting 
compliance with its periodic reporting obligations at the address shown 
in its then-most recent filing with the Commission, but ACCE did not 
receive the delinquency letter due to its failure to maintain a valid 
address on file with the Commission as required by Commission rules 
(Rule 301 of Regulation S-T, 17 CFR 232.301 and Section 5.4 of the 
EDGAR Filer Manual).
---------------------------------------------------------------------------

    \1\ The short form of each issuer's name is also its ticker 
symbol.
---------------------------------------------------------------------------

    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
FirstBank Financial Services, Inc. (CIK No. 1316410) (``FBFS''), a non-
compliant Georgia corporation with its principal place of business in 
McDonough, Georgia, with stock quoted on OTC Link, because it has not 
filed any periodic reports since the period ended June 30, 2008. On 
November 22, 2011, Corporation Finance sent a delinquency letter to 
FBFS requesting compliance with its periodic reporting obligations at 
the address shown in its then-most recent filing with the Commission, 
but FBFS did not receive the delinquency letter due to its failure to 
maintain a valid address on file with the Commission as required by 
Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and 
Section 5.4 of the EDGAR Filer Manual).
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
MicroSmart Devices, Inc. (CIK No. 1339225) (``MCMV''), a Nevada 
corporation with its principal place of business in Litchfield, 
Connecticut, with stock quoted on OTC Link, because it has not filed 
any periodic reports since the period ended September 30, 2012. On June 
6, 2014, Corporation Finance sent a delinquency letter to MCMV 
requesting compliance with its periodic reporting obligations at the 
address shown in its then-most recent filing with the Commission, but 
MCMV did not receive the delinquency letter due to its failure to 
maintain a valid address on file with the Commission as required by 
Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and 
Section 5.4 of the EDGAR Filer Manual).
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Polymedix, Inc. (CIK No. 1341843) (``PYMXQ''), a void Delaware 
corporation with its principal place of business in Radnor, 
Pennsylvania, with stock quoted on OTC Link, because it has not filed 
any periodic reports since the period ended September 30, 2012. On May 
7, 2015, Corporation Finance sent a delinquency letter to PYMXQ 
requesting compliance with its periodic reporting obligations at the 
address shown in its then-most recent filing with the Commission, but 
PYMXQ did not receive the delinquency letter due to its failure to 
maintain a valid address on file with the Commission as required by 
Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and 
Section 5.4 of the EDGAR Filer Manual).
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
RegenoCELL Therapeutics, Inc. (CIK No. 1221749) (``RCLL''), a Florida 
corporation with its principal place of business in Natick, 
Massachusetts, with stock quoted on OTC Link because it has not filed 
any periodic reports since the period ended December 31, 2011. On 
September 16, 2014, Corporation Finance sent a delinquency letter to 
RCLL requesting compliance with its periodic reporting obligations at 
the address shown in its then-most recent filing with the Commission, 
but RCLL did not receive the delinquency letter due to its failure to 
maintain a valid address on file with the Commission as required by 
Commission rules (Rule 301 of Regulation S-T, 17 CFR 232.301 and 
Section 5.4 of the EDGAR Filer Manual).
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
The

[[Page 37330]]

Sagemark Companies Ltd. (CIK No. 89041) (``SKCO''), a New York 
corporation with its principal place of business in New York, New York, 
with stock quoted on OTC Link because it has not filed any periodic 
reports since the period ended September 30, 2012. On September 16, 
2014, Corporation Finance sent a delinquency letter to SKCO requesting 
compliance with its periodic reporting obligations at the address shown 
in its then-most recent filing with the Commission, but SKCO did not 
receive the delinquency letter due to its failure to maintain a valid 
address on file with the Commission as required by Commission rules 
(Rule 301 of Regulation S-T, 17 CFR 232.301 and Section 5.4 of the 
EDGAR Filer Manual).
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies. Therefore, it is ordered, 
pursuant to Section 12(k) of the Securities Exchange Act of 1934, that 
trading in the securities of the above-listed companies is suspended 
for the period from 9:30 a.m. EDT on June 26, 2015, through 11:59 p.m. 
EDT on July 10, 2015.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2015-16147 Filed 6-26-15; 4:15 pm]
 BILLING CODE 8011-01-P